查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953410

軟性內視鏡市場 - 全球產業規模、佔有率、趨勢、機會及按類型、最終用途、地區和競爭格局分類的預測（2021-2031年）

Flexible Endoscopes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球軟性內視鏡市場預計將從 2025 年的 84.1 億美元成長到 2031 年的 129.9 億美元，複合年成長率為 7.51%。

軟性內視鏡是一種將光學元件和工作通道整合到軟性插入管中的醫療設備，使醫生能夠透過自然腔道觀察體內器官並進行手術。市場成長的主要驅動力是全球人口快速老化以及需要頻繁診斷的慢性病發病率不斷上升。此外，微創手術的普及也進一步推動了市場需求，因為微創手術的恢復時間比傳統手術更短。例如，美國癌症協會估計，到2025年，美國將新增154,270例大腸癌病例，這將持續推高對內視鏡檢查的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 84.1億美元
市場規模：2031年 129.9億美元
複合年成長率：2026-2031年 7.51%
成長最快的細分市場 大腸鏡檢查
最大的市場 北美洲

儘管有這些正面趨勢，但市場在預防感染傳播所需的嚴格再處理標準方面仍面臨重大挑戰。徹底消毒這些複雜的重複使用設備存在困難，這會使醫療機構面臨責任風險並降低營運效率。這個問題會導致高昂的維護成本，並需要嚴格遵守監管規定，這可能會阻礙資源匱乏地區廣泛採用此類設備。此外，醫療機構可能被迫承擔一次性替代品的高成本。

市場促進因素

一次性軟式內視鏡的快速普及正在從根本上改變市場格局，有效解決了交叉感染和器械供應等關鍵挑戰。醫療機構正日益轉向使用經過消毒的一次性器械，以降低複雜可重複使用器械再處理的風險，尤其是在加護病房等高使用率環境中。此外，消除昂貴的維修和消毒流程、提高營運效率也是推動這項轉變的重要因素。市場對這些解決方案的強勁需求也反映在近期的公司業績中。例如，Ambu A/S 在其 2024 年 11 月發布的 2023/24 年度報告中指出，其內視鏡解決方案業務實現了 19.7% 的有機銷售成長，主要得益於其在肺科和泌尿系統領域一次性產品系列的擴張。

同時，慢性消化器官系統和呼吸系統疾病的日益普遍正推動全球診斷和治療性內視鏡手術數量的成長。隨著人口老化和風險因素暴露的增加，胃癌和肺癌等疾病負擔日益加重，需要頻繁的篩檢和微創治療。世界衛生組織（世衛組織）於2024年2月發布的《全球癌症負擔日益加重》報告顯示，肺癌仍是全球最常見的癌症類型，新增病例達250萬例。這凸顯了對先進支氣管鏡技術的迫切需求。這種快速成長的臨床需求正直接轉化為主要醫療設備製造商的顯著收入成長。例如，波士頓科學公司內視鏡部門2024年的年淨銷售額達到26.87億美元，反映了其對這些技術的持續依賴。

市場挑戰

為防止感染傳播而製定的嚴格再處理標準是全球軟式內視鏡市場擴張的一大障礙。軟式內視鏡內部結構複雜，包含複雜的通道和升降機構，極易累積有機碎屑和生物膜，使得有效消毒極為困難且耗費人力。這種複雜性要求醫療機構投入大量資源用於清潔通訊協定，顯著降低了設備周轉率，並限制了每日接診患者的數量。由此導致的營運效率降低和維護成本增加，阻礙了小規模醫療中心擴展其內視鏡診療能力，從而限制了整體市場規模。

業界權威機構的安全數據凸顯了器械再處理挑戰的嚴峻性。根據歐洲感染控制研究所 (ECRI) 預測，到 2024 年，不充分或繁瑣的設備清潔程序將被列為全球第二大醫療技術風險，這凸顯了醫療機構在對複雜、可重複使用的器械進行消毒方面持續面臨的困難。這種高風險狀況要求嚴格遵守監管規定，這會消耗醫院預算，並擠佔原本可用於購買更多內視鏡設備的資金。因此，與感染控制相關的財務和法律責任負擔直接限制了可重複使用軟式內視鏡的廣泛應用。

市場趨勢

人工智慧 (AI) 驅動的即時病變檢測技術的整合，透過在內鏡檢查過程中充當自動化的第二觀察者，從根本上改變了診斷標準。這些系統利用深度學習演算法即時分析影像數據，識別潛在的異常情況，例如結腸息肉，而這些異常情況可能因疲勞或注意力分散而被人眼忽略。這項技術變革直接解決了醫師腺瘤檢出率差異這一臨床難題，有效地建立了新的檢查品質標準。隨著主要製造商將人工智慧處理器整合到其旗艦平台中，這些功能的市場應用正在迅速加速。例如，Olympus Corporation在其 2024 年 5 月發布的「2024 會計年度合併會計」中報告稱，其人工智慧 EVIS X1 系列產品在第四季度的銷售額約佔其胃腸內視鏡部門總銷售額的 30%，這標誌著公司正向智慧視覺化系統進行決定性的商業性轉型。

同時，機器人輔助軟式內視鏡平台的出現正在擴大市場覆蓋範圍，尤其是在肺科複雜解剖路徑的導航方面。與傳統的手動支氣管鏡不同，這些機器人系統採用可彎曲導管和形狀感知技術，在進入難以觸及的外周肺結節時能夠保持穩定性和精確性。這種增強的操控性顯著提高了早期癌症切片檢查的診斷率，促使醫院將介入治療能力擴展到標準範圍之外。近期部署數據也印證了對這些先進平台的需求。根據直覺外科公司（Intuitive Surgical）於2024年10月發布的“2024年第三季度財務業績”，Ion內視鏡系統的全球部署量達到736台，同比成長50%，反映出該領域正穩步轉向機器人導航解決方案。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球軟性內視鏡市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（腹腔鏡、關節鏡、輸尿管鏡、膀胱鏡、婦科內視鏡、神經內視神經科學用內視鏡、子宮鏡、喉鏡、鼻竇鏡、耳鏡、乙狀結腸鏡、咽鏡、十二指腸鏡、鼻咽鏡、鼻鏡、大腸鏡）
    • 按用途（醫院、門診機構）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美軟性內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲軟性內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區軟性內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲軟性內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲軟性內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球軟性內視鏡市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith n Nephew Inc.
  • FUJIFILM Holdings Corp.
  • Ambu A/S
  • Stryker Corporation
  • Boston Scientific Corp
  • Karl Storz SE & Co. KG
  • Medtronic Plc
  • Ethicon, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24042

The Global Flexible Endoscopes Market is projected to grow from USD 8.41 Billion in 2025 to USD 12.99 Billion by 2031, registering a CAGR of 7.51%. Flexible endoscopes are defined as medical instruments featuring a pliable insertion tube with integrated optics and working channels, enabling physicians to visualize internal organs and conduct procedures through natural body openings. Market growth is primarily driven by the rapidly aging global population and the rising incidence of chronic conditions necessitating frequent diagnostics. Furthermore, the shift toward minimally invasive surgeries supports demand, as these techniques offer shorter recovery times than traditional methods. For instance, the American Cancer Society estimates that 154,270 new cases of colorectal cancer will be diagnosed in the United States in 2025, ensuring sustained demand for endoscopic screening.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.41 Billion
Market Size 2031USD 12.99 Billion
CAGR 2026-20317.51%
Fastest Growing SegmentColonoscopes
Largest MarketNorth America

Despite this positive trajectory, the market faces a significant challenge regarding the rigorous reprocessing standards needed to prevent infection transmission. The difficulty inherent in thoroughly sterilizing these complex reusable devices creates liability risks and operational inefficiencies for healthcare providers. This issue leads to high maintenance costs and requires strict regulatory compliance, factors that may hinder broader adoption in resource-constrained settings or compel facilities to incur the high costs associated with disposable alternatives.

Market Driver

The rapid uptake of single-use and disposable flexible endoscopes is fundamentally reshaping the market by resolving critical issues regarding cross-contamination and device availability. Healthcare facilities are increasingly switching to sterile, single-use devices to mitigate risks associated with reprocessing complex reusable instruments, especially in high-volume environments like intensive care units. This transition is also motivated by the need to eliminate expensive repair and sterilization workflows, thereby enhancing operational efficiency. The strong market demand for these solutions is reflected in recent corporate performance; for example, Ambu A/S reported in November 2024 within its 'Annual Report 2023/24' that its Endoscopy Solutions business achieved 19.7% organic revenue growth, largely fueled by the expansion of its disposable product portfolio in pulmonology and urology.

Concurrently, the rising prevalence of chronic gastrointestinal and respiratory disorders is driving a higher volume of diagnostic and therapeutic endoscopic procedures globally. As populations age and exposure to risk factors grows, the burden of conditions such as gastric and lung cancers necessitates frequent screening and minimally invasive interventions. According to the World Health Organization's February 2024 'Global cancer burden growing' release, lung cancer was the most common cancer worldwide with 2.5 million new cases, highlighting the critical need for advanced bronchoscopic capabilities. This surging clinical demand translates directly into substantial financial expansion for leading device manufacturers; for instance, Boston Scientific recorded annual net sales of $2.687 billion for its Endoscopy business segment in 2024, reflecting sustained reliance on these technologies.

Market Challenge

The rigorous reprocessing standards required to prevent infection transmission act as a critical barrier impeding the expansion of the Global Flexible Endoscopes Market. Flexible endoscopes possess intricate internal channels and elevator mechanisms that are highly susceptible to retaining organic debris and biofilm, making effective sterilization exceptionally difficult and labor-intensive. This complexity forces healthcare facilities to dedicate significant resources to cleaning protocols, which considerably slows device turnover and limits daily patient throughput. The resulting operational inefficiencies and elevated maintenance costs discourage smaller healthcare centers from expanding their endoscopic capabilities, thereby stifling overall market volume.

The magnitude of this reprocessing challenge is highlighted by safety data from industry authorities. According to ECRI, in 2024, inadequate or onerous device cleaning instructions were ranked as the second highest health technology hazard globally, underscoring the persistent difficulty providers face in sterilizing complex reusable instruments. This heightened risk profile necessitates strict regulatory compliance that consumes hospital budgets, diverting funds that might otherwise be used to purchase additional endoscopic units. Consequently, the financial and liability burdens associated with infection control directly restrict the broader adoption of reusable flexible endoscopes.

Market Trends

The integration of Artificial Intelligence (AI) for real-time lesion detection is fundamentally altering diagnostic standards by serving as an automated second observer during endoscopic procedures. These systems utilize deep learning algorithms to analyze video feeds instantaneously, flagging potential abnormalities such as colorectal polyps that might be missed by the human eye due to fatigue or distraction. This technological shift directly addresses the clinical challenge of variable adenoma detection rates among physicians, effectively creating a new baseline for procedural quality. Market adoption of these capabilities is accelerating rapidly as major manufacturers embed AI-driven processors into their flagship platforms; for instance, Olympus Corporation reported in May 2024, in its 'Consolidated Financial Results for Fiscal 2024', that the sales ratio of the AI-capable EVIS X1 series rose to approximately 30% of the company's total Gastrointestinal Endoscopy sales in the fourth quarter, signaling a decisive commercial shift toward intelligent visualization systems.

Simultaneously, the emergence of robotic-assisted flexible endoscopy platforms is expanding the market's operational boundaries, particularly for navigating complex anatomical pathways in pulmonology. Unlike traditional manual bronchoscopes, these robotic systems employ articulating catheters and shape-sensing technology to maintain stability and precision when accessing peripheral lung nodules, which are often difficult to reach. This enhanced maneuverability significantly improves diagnostic yield for early-stage cancer biopsies, driving hospitals to upgrade their interventional capabilities beyond standard limits. The demand for these advanced platforms is evident in recent installation data; according to Intuitive Surgical's October 2024 'Q3 2024 Earnings Release', the global installed base of the Ion Endoluminal System increased 50% year-over-year to 736 units, reflecting the sector's robust transition toward robotic navigation solutions.

Key Market Players

  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith n Nephew Inc.
  • FUJIFILM Holdings Corp.
  • Ambu A/S
  • Stryker Corporation
  • Boston Scientific Corp
  • Karl Storz SE & Co. KG
  • Medtronic Plc
  • Ethicon, Inc.

Report Scope

In this report, the Global Flexible Endoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flexible Endoscopes Market, By Type

  • Laparoscopes
  • Arthroscopes
  • Ureteroscopes
  • Cystoscopes
  • Gynecology Endoscopes
  • Neuroendoscopes
  • Bronchoscopes
  • Hysteroscopes
  • Laryngoscopes
  • Sinuscopes
  • Otoscopes
  • Sigmoidoscopes
  • Pharyngoscopes
  • Duodenoscope
  • Nasopharyngoscopes
  • Rhinoscopes
  • Colonoscopes

Flexible Endoscopes Market, By End Use

  • Hospital
  • Outpatients Facilities

Flexible Endoscopes Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flexible Endoscopes Market.

Available Customizations:

Global Flexible Endoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flexible Endoscopes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes, Bronchoscopes, Hysteroscopes, Laryngoscopes, Sinuscopes, Otoscopes, Sigmoidoscopes, Pharyngoscopes, Duodenoscope, Nasopharyngoscopes, Rhinoscopes, Colonoscopes)
    • 5.2.2. By End Use (Hospital, Outpatients Facilities)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Flexible Endoscopes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Flexible Endoscopes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Flexible Endoscopes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Flexible Endoscopes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Flexible Endoscopes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Flexible Endoscopes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Flexible Endoscopes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Flexible Endoscopes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Flexible Endoscopes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Flexible Endoscopes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End Use

8. Asia Pacific Flexible Endoscopes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Flexible Endoscopes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Flexible Endoscopes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Flexible Endoscopes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Flexible Endoscopes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Flexible Endoscopes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Flexible Endoscopes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Flexible Endoscopes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Flexible Endoscopes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Flexible Endoscopes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End Use

10. South America Flexible Endoscopes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Flexible Endoscopes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Flexible Endoscopes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Flexible Endoscopes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Flexible Endoscopes Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Olympus Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Richard Wolf GmbH
  • 15.3. Smith n Nephew Inc.
  • 15.4. FUJIFILM Holdings Corp.
  • 15.5. Ambu A/S
  • 15.6. Stryker Corporation
  • 15.7. Boston Scientific Corp
  • 15.8. Karl Storz SE & Co. KG
  • 15.9. Medtronic Plc
  • 15.10. Ethicon, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer